[go: up one dir, main page]

DE4192786T1 - Measles Virus Recombinant Smallpox Virus Vaccine - Google Patents

Measles Virus Recombinant Smallpox Virus Vaccine

Info

Publication number
DE4192786T1
DE4192786T1 DE4192786T DE4192786T DE4192786T1 DE 4192786 T1 DE4192786 T1 DE 4192786T1 DE 4192786 T DE4192786 T DE 4192786T DE 4192786 T DE4192786 T DE 4192786T DE 4192786 T1 DE4192786 T1 DE 4192786T1
Authority
DE
Germany
Prior art keywords
virus
vaccine
measles
recombinant smallpox
measles virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE4192786T
Other languages
German (de)
Other versions
DE4192786B4 (en
Inventor
Enzo Paoletti
Jill Taylor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Virogenetics Corp
Original Assignee
Virogenetics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virogenetics Corp filed Critical Virogenetics Corp
Publication of DE4192786T1 publication Critical patent/DE4192786T1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE4192786T 1990-11-20 1991-11-20 Measles Virus Recombinant Smallpox Virus Vaccine Pending DE4192786T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62161490A 1990-11-20 1990-11-20
US77686791A 1991-10-22 1991-10-22

Publications (1)

Publication Number Publication Date
DE4192786T1 true DE4192786T1 (en) 1994-01-13

Family

ID=27089007

Family Applications (2)

Application Number Title Priority Date Filing Date
DE4192786A Expired - Lifetime DE4192786B4 (en) 1990-11-20 1991-11-20 Measles virus recombinant poxvirus vaccine
DE4192786T Pending DE4192786T1 (en) 1990-11-20 1991-11-20 Measles Virus Recombinant Smallpox Virus Vaccine

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE4192786A Expired - Lifetime DE4192786B4 (en) 1990-11-20 1991-11-20 Measles virus recombinant poxvirus vaccine

Country Status (12)

Country Link
JP (2) JP3617668B2 (en)
AU (1) AU1253892A (en)
BE (1) BE1005908A5 (en)
CA (1) CA2096633A1 (en)
CH (1) CH683921A5 (en)
DE (2) DE4192786B4 (en)
FR (1) FR2669346B1 (en)
GB (2) GB2283021B (en)
IE (2) IE71643B1 (en)
IT (1) IT1252687B (en)
NL (2) NL195058C (en)
WO (1) WO1992008789A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5833975A (en) * 1989-03-08 1998-11-10 Virogenetics Corporation Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
US5505941A (en) * 1981-12-24 1996-04-09 Health Research, Inc. Recombinant avipox virus and method to induce an immune response
US5338683A (en) 1981-12-24 1994-08-16 Health Research Incorporated Vaccinia virus containing DNA sequences encoding herpesvirus glycoproteins
US7767449B1 (en) 1981-12-24 2010-08-03 Health Research Incorporated Methods using modified vaccinia virus
US6248333B1 (en) 1990-04-04 2001-06-19 Health Research Inc. Isolated nucleic acid sequence of equine herpesvirus type 1 glycoprotein D (EHV-1 gD)
US5756102A (en) * 1990-11-20 1998-05-26 Virogenetics Corporation Poxvirus-canine distemper virus (CDV) recombinants and compositions and methods employing the recombinants
JP3602530B2 (en) * 1991-03-07 2004-12-15 ヴァイロジェネティクス コーポレイション Genetically engineered vaccine strain
US5989561A (en) * 1991-03-07 1999-11-23 Virogenetics Corporation Recombinant poxvirus-calicivirus rabbit hemorrhagic disease virus (RHDV) compositions and uses
AU672581B2 (en) * 1991-03-07 1996-10-10 Virogenetics Corporation Immunodeficiency virus recombinant poxvirus vaccine
JPH06505397A (en) * 1991-03-20 1994-06-23 ヴァイロジェネティクス　コーポレイション malaria recombinant poxvirus
US5643578A (en) 1992-03-23 1997-07-01 University Of Massachusetts Medical Center Immunization by inoculation of DNA transcription unit
CN1089370C (en) * 1994-12-08 2002-08-21 中国预防医学科学研究院病毒学研究所 Recombination vaccinia virus for expression of measles virus L4 strain hemagglutinin and fusion protein gene
AU2118997A (en) * 1996-02-05 1997-08-22 Johns Hopkins University, The Measles immunization by dna transcription unit inoculation
US6211165B1 (en) 1997-05-09 2001-04-03 The Trustees Of The University Of Pennsylvania Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists
EP1095948A1 (en) * 1999-10-28 2001-05-02 Universitätsklinikum Freiburg Idiotype vaccines
CA2454959C (en) 2001-03-08 2018-07-10 Bernard Moss Mva expressing modified hiv envelope, gag, and pol genes
AR052743A1 (en) * 2006-04-11 2007-03-28 Inst Nac De Tecnologia Agropec PLASMIDIC TRANSFER VECTOR AND RECOMBINANT CANARYPOX VIRUS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2617715B1 (en) * 1987-07-07 1990-08-31 Transgene Sa VIRAL VECTOR AND RECOMBINANT DNA ENCODING FOR ONE OR MORE SURFACE PROTEINS (HA AND / OR F) OF A MORBILLIVIRUS, INFECTED CELL CULTURE, PROTEINS OBTAINED, VACCINE AND ANTIBODIES OBTAINED
DE10399031I1 (en) * 1987-08-28 2004-01-29 Health Research Inc Recombinant viruses.
FR2632863B2 (en) * 1987-10-29 1990-08-31 Transgene Sa RECOMBINANT FOWLPOX VIRUS AND VACCINES DERIVED FROM SUCH VIRUSES
JPH01218590A (en) * 1988-02-29 1989-08-31 Toa Nenryo Kogyo Kk Rinderpest virus vaccine using recombinant vaccinia virus

Also Published As

Publication number Publication date
GB2264949A (en) 1993-09-15
IE68404B1 (en) 1996-06-12
AU1253892A (en) 1992-06-11
IE913960A1 (en) 1992-05-20
JPH06502996A (en) 1994-04-07
NL9120026A (en) 1993-09-01
GB9309414D0 (en) 1993-07-14
NL9900036A (en) 2003-10-01
CH683921A5 (en) 1994-06-15
ITMI913092A1 (en) 1993-05-20
NL195058C (en) 2003-07-01
FR2669346A1 (en) 1992-05-22
IE71643B1 (en) 1997-02-26
BE1005908A5 (en) 1994-03-08
NL195095C (en) 2004-01-21
GB9500214D0 (en) 1995-03-01
GB2264949B (en) 1995-07-05
DE4192786B4 (en) 2006-08-24
GB2283021A (en) 1995-04-26
FR2669346B1 (en) 1995-07-21
JP2005040129A (en) 2005-02-17
CA2096633A1 (en) 1992-05-21
WO1992008789A1 (en) 1992-05-29
GB2283021B (en) 1995-07-05
JP3617668B2 (en) 2005-02-09
JP3824619B2 (en) 2006-09-20
ITMI913092A0 (en) 1991-11-20
IT1252687B (en) 1995-06-23

Similar Documents

Publication Publication Date Title
ATA902590A (en) RECOMBINANT SMALL VIRUS
DE4090351T1 (en) Recombinant smallpox virus host selection system
DK603888D0 (en) RECOMBINANT VIRUS
FR2621487B1 (en) RECOMBINANT AVIPOX VIRUS
DK0512017T3 (en) vaccines
DE4192786T1 (en) Measles Virus Recombinant Smallpox Virus Vaccine
FR2620459B1 (en) RECOMBINANT VACCINE VIRUS
DE69016956D1 (en) Recombinant turkey herpes virus and derived live vaccine vector.
CY2007015I1 (en) HPV VACCINE
ATE275631T1 (en) RECOMBINANT VENEZOLAN EQUINE EQUINO CEPHALITIS VIRUS VACCINE
DE3853088D1 (en) Recombinant avipox virus.
DE69230627D1 (en) Recombinant avipox virus
DE3850019D1 (en) Recombinant avipox virus.
FI942369L (en) Hepatitis C virus test
DE69101683D1 (en) Recombinant Mareks disease virus.
FI950567A0 (en) Hepatitis A virus vaccine
FI933495L (en) Recombinant adenovirus vaccine
FI943626L (en) Recombinant adenovirus vaccines
FI925032L (en) VACCINE COMBINATIONS
FI934777A0 (en) MULTIPEL HEPATITIS B VIRUS YTPROTEINER SOM BILDAR PARTIKLAR
KR890701743A (en) Hepatitis B surface antigen vaccine
EP0537232A4 (en) Recombinant pigeon pox virus vaccine
DK0547446T3 (en) Vaccines based on altered bovine herpes virus type 1
DK219187A (en) RECOMBINANT VIRUS
FI943929A0 (en) Hepatitis C virus peptides